Episode Notes
In this episode, DASON Clinical Pharmacist Liaison, Dr. April Dyer, talk to us about a publication in Health Affairs Scholar, entitled "Sustainable solutions to the continuous threat of antimicrobial resistance." The article can be viewed here: https://pubmed.ncbi.nlm.nih.gov/39916975/
For more information about DASON, please visit: https://dason.medicine.duke.edu/
--------
11:44
--------
11:44
Ep.121 – PEP Talk: Navigating the New HIV Occupational Guideline
Episode Notes
In this episode, DASON Clinical Pharmacist Liaison and Operations Director, Dr. Libby Dodds Ashley, talks with Duke University Hospital Clinical Pharmacist, Dr. Jenna Januszka about the recent ICHE publication "2025 US Public Health Service Guidelines for the Management of Occupational Exposures to Human Immunodeficiency Virus and Recommendations for Post-exposure Prophylaxis in Healthcare Settings."
For more information about DASON, please visit: https://dason.medicine.duke.edu/
--------
12:45
--------
12:45
Antibiotic Dosing in Obesity: What the Largest PK Review Reveals
In this episode of the DASON Digest podcast, DASON Clinical Pharmacist Liaison, Dr. Angelina Davis, talks about the pharmacokinetics of antibiotics in patients with obesity. The article reviewed in this episode can be found here: https://pubmed.ncbi.nlm.nih.gov/40383125/
For more information about DASON, please visit: https://dason.medicine.duke.edu/
--------
15:44
--------
15:44
Ep.119 – New Rules for Old Infections: What the DOTS Trial Tells Us
Episode Notes
Join DASON Clinical Pharmacist Liaison Jeannette Bouchard as she speaks with Dr. Nick Turner, lead author of the DOTS randomized clinical trial, about the potential of dalbavancin as a simplified treatment for Staphylococcus aureus bacteremia. They discuss the trial’s findings, its implications for clinical practice, and whether two doses can truly replace weeks of IV antibiotics. The materials reviewed in this episode can be found here: https://dason.medicine.duke.edu/blog/new-rules-old-infections-what-dots-trial-tells-us
For more information about DASON, please visit: https://dason.medicine.duke.edu
--------
31:05
--------
31:05
Ep.118 – Combatting unnecessary ASB treatment through diagnostic stewardship – which approach works?
Episode Notes
In this episode, Dr. Melissa Johnson, one of our DASON Clinical Pharmacist Liaisons, talks with Dr. Kim Claeys, from the University of Maryland, about her recent work on the implementation diagnostic stewardship to improve UTI antibiotic use. The two publications referenced in this episode can be found here: https://pubmed.ncbi.nlm.nih.gov/40720743/ and here: https://pubmed.ncbi.nlm.nih.gov/37424224/
For more information about DASON, please visit: https://dason.medicine.duke.edu/
The DASON Digest features engaging conversations with experts in infectious diseases and antimicrobial stewardship covering a variety of topics. New episodes of the Digest are published every other Friday. Subscribe to follow along with our latest content.
For more information about DASON, please visit https://dason.medicine.duke.edu.
Brasil